QGQiongqiong Gao

Qiongqiong Gao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qiongqiong Gao has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Chi Zhang

    Department of Urology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, P. R. China

    2 shared publications
  • Minzhi Su

    Department of Rehabilitation, The Third Affiliated Hospital and Lingnan Hospital of the Sun Yat-Sen University, 2693 Kaichuang Road, Guangzhou 510700, China

    2 shared publications
  • Yong Huang

    Department of Urology, The Third Affiliated Hospital and Lingnan Hospital of the Sun Yat-Sen University, 2693 Kaichuang Road, Guangzhou 510700, China

    2 shared publications
  • Bolong Liu

    Department of Urology, The Third Affiliated Hospital of Sun Yet-sun University

    1 shared publication
  • Bolong Liu

    Department of Urology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, PR China

    1 shared publication
  • Chi Zhang

    Department of Urology, The Third Affiliated Hospital of Sun Yat-Sen University

    1 shared publication

Latest Publications

  • Overexpression of Heme Oxygenase 1 Enhances the Neuroprotective Effects of Exosomes in Subarachnoid Hemorrhage by Suppressing Oxidative Stress and Endoplasmic Reticulum Stress

    by Qiongqiong Gao, Zhumin Su, Xiangxiong Pang, Jinshuo Chen, Ruixiang Luo, Xiaoyang Li, Chi Zhang, Yun Zhao

    Aims This study aims to elucidate the therapeutic effects and underlying mechanisms of exosomes derived from Heme oxygenase 1 (HO-1)-overexpressing human umbilical cord mesenchymal stem cells (ExoHO−1) in a subarachnoid hemorrhage (SAH) mouse model. Methods In this study, exosomes were identified using Western blotting, particle analysis, and transmission electron microscopy. The effect of ExoHO−1 and ExoCtrl on the neurological function of SAH mice was assessed using the Garcia scoring system, Beam balance, Rotarod test, and Morris water maze test. Neuronal apoptosis and survival were evaluated through TUNEL and Nissl staining. Levels of oxidative and endoplasmic reticulum stress were measured via immunofluorescence, Western blotting, DHE staining, enzyme-linked immunosorbent assay, and commercial kits. Results HO-1-overexpressing human umbilical cord mesenchymal stem cells encapsulated HO-1 into their exosomes. ExoHO−1 significantly enhanced both short-term and long-term neurological function protection. By reducing the activation of the PERK/CHOP/Caspase12 pathway and decreasing oxidative stress levels, ExoHO−1 effectively inhibited neuronal apoptosis in the ipsilateral temporal cortex. Conclusion ExoHO−1 enhances the therapeutic efficacy of exosomes in SAH mice by countering neuronal apoptosis, primarily through the suppression of oxidative and endoplasmic reticulum stress. Graphical Abstract Schematic drawing of neuroprotective effects of ExoHO-1. After SAH, ExoHO-1 exhibited enhanced inhibitory effects on neuroinflammation and neuronal apoptosis. Those effects partially through inhibiting endoplasmic reticulum stress and oxidative stress following SAH


  • Open Access

    Umbilical Cord Mesenchymal Stem Cells Overexpressing Heme Oxygenase-1 Promotes Symptoms Recovery in Cystitis Rats by Alleviating Neuroinflammation

    by Qiongqiong Gao, Zhentao Gao, Minzhi Su, Yong Huang, Chi Zhang, Cuiping Li, Hailun Zhan, Bolong Liu, Xiangfu Zhou

    Interstitial cystitis/bladder pain syndrome (IC/BPS) seriously reduces the patient’s quality of life, yet current therapies only provide partial relief. In the spinal dorsal horn (SDH), neuroinflammation plays a pivotal role in the development of IC. Injection of human umbilical cord mesenchymal stem cells (hUMSCs) to reduce inflammation is an effective strategy, and heme oxygenase-1 (HO-1) exhibits anti-nociceptive effect in neuroinflammatory pain. This study aimed to test the therapeutic effects of hUMSCs overexpressing HO-1 on cyclophosphamide-induced cystitis rat model. Cystitis rats were transplanted with altered cells and then assessed for 3 weeks. A series of behavioral measurements would be trial including suprapubic mechanical allodynia, depressive-like behaviors, micturition frequency, and short-term memory function. Additionally, western blot, immunofluorescence staining, and ELISA kit test for anti-inflammation effect. HUMSCs were capable of being transduced to overexpress HO-1. Injection of hUMSCs overexpressing HO-1 was more effective than hUMSCs alone in alleviating behavioral symptoms in rats. Furthermore, hUMSCs overexpressing HO-1 inhibited the activation of glial and TLR4/p65/NLRP3 pathway, decreased the levels of pro-inflammatory cytokines in the SDH region. Surprisingly, it markedly increased anti-inflammatory cytokine IL-10, reduced MDA content, and protected GSH concentrations in local environment. Our results suggest that injecting hUMSCs overexpressing HO-1 intrathecally can significantly promote functional outcomes in cystitis rats by reducing neuroinflammation, at least, partly through downregulating TLR4/p65/NLRP3 signaling pathway in the SDH region. This cell therapy affords a new strategy for IC/BPS treatment.


  • Open Access

    Intrathecal injection of human umbilical cord mesenchymal stem cells genetically engineered to overexpress Heme oxygenase 1 promotes symptoms recovery in cyclophosphamide-induced cystitis rats by alleviating neuroinflammation

    by Qiongqiong Gao, Zhentao Gao, Yong Huang, Chi Zhang, Minzhi Su, Cuiping Li, Hailun Zhan, Bolong Liu, Xiangfu Zhou

    Background Interstitial cystitis/bladder pain syndrome (IC/BPS) seriously affect the patient's quality of life, yet current therapies for IC/BPS only provide partial relief. Neuroinflammation in the spinal dorsal horn (SDH) plays a pivotal role in the pathogenesis. Injection of human umbilical mesenchymal stem cells (hUMSCs) represent an effective strategy to reduce inflammation, and heme oxygenase-1 (HO-1) has anti-nociceptive effect in neuro inflammatory pain. This study aimed to tested the therapeutic effects of hUMSCs overexpressing HO-1 on cyclophosphamide-induced cystitis rat model. Methods Cystitis rats were transplanted with altered cells and then assessed for 3 weeks on a battery of behavioral tests that measured suprapubic mechanical allodynia, micturition frequency, depressive-like behaviors and short-term memory function. Additionally, immunofluorescence staining, western blot and Elisa kit measured the anti-inflammation effects. Results HUMSCs were capable of being transduced to overexpress HO-1 in vitro and in vivo. Treatment with hUMSCs overexpressing HO-1 was more effective than hUMSCs alone in alleviating suprapubic mechanical allodynia and frequent micturition in cystitis rats. Furthermore, rats treated with hUMSCs overexpressing HO-1 relieved the comorbid depressive-like behaviors and memory deficits. In the SDH region, hUMSCs overexpressing HO-1 inhibited the activation of glial, decreased the levels of pro-inflammatory cytokines by downregulating the TLR4/p65/NLRP3 pathway. And surprisingly, it markedly increased anti-inflammatory cytokine IL-10, while reduced MDA content and protected GSH concentrations in local environment. Conclusions Overall, our result suggest that intrathecal injection of hUMSCs overexpressing HO-1 can significantly promote functional outcomes in cystitis rats by reducing neuroinflammation, at least, partly through downregulating TLR4/p65/NLRP3 signaling pathway in the SDH region. This cell therapy providing a possible new strategy for treating IC/BPS.